
ABOUT IPS
IPS-Integrated Project Services is a global provider of technical consulting, architecture, engineering, project controls, construction management, and CGMP compliance services for technically complex pharmaceutical development and manufacturing facilities worldwide.
CONTACT INFORMATION
IPS-Integrated Project Services
721 Arbor Way, Suite 100
Blue Bell, PA 19422
UNITED STATES
Phone: 610.828.4090
Contact: Sales
FEATURED ARTICLES
-
The need to adapt and expand your CAR-T operation efficiently and effectively has never been more critical than it is in the current and rapidly evolving landscape of cellular therapies.
-
To keep up with the accelerated pace of research, flexible labs will be necessary for our brilliant scientists to access a changing array of instruments as hypotheses emerge and assessments evolve.
-
Although the fundamental processes and technologies supporting CAR-T production are essentially universal, the diversity of these products can necessitate a closer look at a facility’s overall design.
-
As more CAR-T therapies achieve commercial success, the current scarcity of specialized manufacturing capacity will only serve to stall production scale-up for these crucial modalities.
-
IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services for the life sciences sector, announces the appointment of Jim Stephanou as its new Chief Executive Officer (CEO) to lead the company into its next phase of growth.
-
Kevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.
-
Learn how implementing flexibility in agile construction, adopting predictive data analytics, and referencing benchmarking data can enable contractors to assist swift vaccine rollout and meet demand for new treatments.
-
The revision to Annex 1 will become effective in August 2023. Explore the major changes and considerations along with the next steps to achieve Annex 1 Regulatory compliance.
-
As the cell and gene therapy industry segment grows, the global supply chain faces constraints. Learn about the supply of these life-saving therapies and what improvements are needed.
-
IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces the continued expansion in Ireland with the announcement of a new office in the city of Cork. As Ireland’s presence in the life sciences industry grows, the demand for our design and engineering services grows alongside it.
-
Learn more about the challenges that arise during the synthesis, purification, and encapsulation of mRNA.
-
Learn 12 strategies and solutions for accelerating the design and construction process that can yield record breaking delivery times.
-
IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its support to Abzena (North Carolina) LLC to perform full design, construction management, and CQV services for their new monoclonal antibody (mAb) facility in Sanford, North Carolina.
-
Read how inceptioneering, an early-stage planning process, can ease the shift from R&D to manufacturing.
-
Read insights into the challenges, solutions, and key considerations to optimize success when looking to radically reduce design and construction schedules for research lab projects.
-
This review suggests technical remedial options for the production of pDNA and focus on mRNA synthesis, purification and encapsulation.
-
Utilize engineering, procurement, construction management, and validation (EPCMV) for rapid delivery of complex projects with tight deadlines and costs from start to finish on your life science capital projects.
-
The Cardinal Group was awarded the project based on an integrated delivery approach, with IPS as the Engineer of Record. Their combined technical expertise and experience is critical to the success of this aggressive schedule-driven project.
-
IPS designed a new 4x2000L (maximum production scale) multi-product, multi-phase monoclonal antibody and vaccine production facility. The greenfield site was designed to seed, scale up, harvest, and purify cell culture and vaccine products utilizing up to 100% single-use systems. The concept included six manufacturing modules of which four were identical to allow for process flexibility of different unit operations, scales, and phases of material. The other two were designed to accommodate formulation of buffer and/or media as well as other additives.
-
Our client’s objective for the flex fill project was to install a new, independent filling suite for manufacturing specialized sterile injectable products. The new line would increase capacity with a state-of-the-art flexible filling line and associated ancillary support functions. This new capability was important as a CMO. Manufacturing continued throughout the duration of the project.